Furthermore, when ROS inhibited the phosphatase CCNB1, leading to the activation of CDK1, it promoted the cycle progression of cancer cells (Takeuchi et al., 2005; Guertin & Sabatini, 2007). This evidence concerns the gene CDK1 and cancer.